study question: What is the subcellular localization in human oocytes and preimplantation embryos, of the two maternal-effect proteins, NLRP7 and KHDC3L, responsible for recurrent hydatidiform moles (RHMs)?
Introduction
A hydatidiform mole (HM) is an abnormal human pregnancy characterized by absence of, or abnormal, embryonic development, excessive trophoblastic proliferation and hydropic degeneration of chorionic villi. The common form of this condition is sporadic, not recurrent, and occurs in 1 in every 600 -1000 pregnancies in Western countries (Savage et al., 2010) . Moles recur in 1-6% of patients with a prior mole and these cases are termed singleton cases of recurrent hydatidiform moles (RHMs). Occasionally, patients with RHMs have relatives with HMs and these cases are designated as familial RHMs.
Owing to the fact that women with RHMs usually fail to have normal pregnancies and continue to have recurrent moles even after changing partners, we suggested that a maternal defective gene is responsible for this condition (Helwani et al., 1999) . Maternal-effect genes encode mRNA and proteins that accumulate during oogenesis and govern the transition from oocyte to embryo (Dean, 2002) . Such genes are not supposed to affect ovulation and fertilization but their absence would lead to early embryonic arrest. By studying rare familial cases of RHMs, two maternal-effect genes, NLRP7 and KHDC3L, responsible for this condition have been identified (Murdoch et al., 2006; Parry et al., 2011) . NLRP7 is a major gene for RHMs and is mutated in 48-80% of patients depending on patients' ascertainment criteria (singleton or familial cases) and populations (Slim et al., 2009; Qian et al., 2011; Estrada et al., 2013; Sebire et al., 2013) . KHDC3L is a minor gene for RHMs and is mutated in only 10 -14% of patients with no NLRP7 mutations (Parry et al., 2011; Fallahian et al., 2013; Reddy et al., 2013) .
NLRP7 transcripts have been documented in all oocyte and preimplantation embryo stages (Murdoch et al., 2006) with levels decreasing from the germinal vesicle to Day 3 embryos (Zhang et al., 2008) . At the protein level, NLRP7 expression in human oocytes has been documented in all follicular stages by immunohistochemistry (Wang et al., 2009) . NLRP7 codes for a nucleotide oligomerization domain-like receptor protein and is a member of the NLRP family with roles in autoinflammation, apoptosis and pathogen-induced inflammation (Tschopp et al., 2003) . Three studies have tried to address the functional role of NLRP7 in inflammation and agree on the fact that NLRP7 down-regulates inflammation in various cellular models (Kinoshita et al., 2005; Messaed et al., 2011; Khare et al., 2012) . Two of these studies also showed that NLRP7 mutations and knock-down reduce the levels of secreted IL1B in peripheral mononuclear blood cells from patients (Messaed et al., 2011) and macrophages (Khare et al., 2012) , respectively. In these cells, NLRP7 localizes to the microtubule organizing center, the Golgi apparatus and associates with microtubules suggesting that it may impair IL1B secretion by affecting the microtubules and consequently the trafficking of IL1B-containing vesicles to the extra-cellular milieu (Messaed et al., 2011) . The role of NLRP7 in down-regulating the inflammatory response is believed to play a secondary role in the pathology of RHMs that underlies the prolonged retention of these pregnancies, in which embryonic development had arrested earlier. However, the primary role of NLRP7 in the pathology of RHMs is believed to be in the oocyte by analogy to other maternal-effect genes and based on the fact that ovum donation has rescued the defect of three patients with recessive mutations in NLRP7 (Fisher et al., 2011; Nguyen and Slim, 2014 ). NLRP7 does not have an ortholog in mouse, but a paralog, Nlrp2, from which NLRP7 is believed to have emerged by gene duplication (Tian et al., 2009 ; Duenez-Guzman and Haig, 2014).
KHDC3L expression was documented at the RNA level in germinal vesicle and metaphase II human oocytes and also at the protein level by immunohistochemistry during early folliculogenesis (Parry et al., 2011) . KHDC3L is a member of the KH protein family characterized by the presence of an N-terminal K homology domain (KH), known to bind RNA (Garcia-Mayoral et al., 2007) . Recently, we showed that KHDC3L co-localizes with NLRP7 in human hematopoietic cells (Reddy et al., 2013) . In addition, Filia, the closest mouse gene to KHDC3L, has been reported to be part of a maternal protein complex confined to the oocyte cortex (Ohsugi et al., 2008) .
Molar tissues from patients with two NLRP7 or KHDC3L mutations are diploid biparental. Despite the normal biparental contribution to their genomes, these tissues lack maternal methylation marks on several maternally imprinted, paternally expressed genes. This has led to the suggestion that NLRP7 and KHDC3L play roles in establishing or maintaining maternal epigenetic marks during oogenesis or post-zygotic development (Judson et al., 2002; El-Maarri et al., 2003; Kou et al., 2008; Hayward et al., 2009) . In line with these data, a recent study demonstrated the implication of NLRP7 in trophoblast lineage differentiation, chromatin reprogramming and DNA methylation (Mahadevan et al., 2014) .
Part of our understanding of the functions of NLRP7 and KHDC3L in the cells where these proteins play their primary roles is in the characterization of their exact subcellular localizations in human oocytes and early embryos. Toward this goal, we used a total of 164 spare human oocytes and embryos to characterize fully the expression of these two proteins. We describe their localization to the oocyte cytoskeleton and show that both proteins redistribute at the 2-cell stage and become polar, restricted to the outer cortical region. Our full characterization of the subcellular localization of NLRP7 and KHDC3L will contribute to a better understanding of the roles of these proteins in the pathophysiology of RHMs.
Materials and Methods

Collection of oocytes and early cleavage embryos
This study was approved by the Institutional Review Board of the McGill University. Patients undergoing IVF, ICSI or/and preimplantation genetic diagnosis were treated with GnRH agonist or antagonists and FSH or hMG in a long-or short-treatment protocols. A single dose of 10 000 IU hCG was administered when two or more follicles reached a diameter above 18 mm. Oocytes were retrieved transvaginally 35 h after hCG injection and were inseminated by either conventional IVF or ICSI. Oocytes and zygotes were cultured in cleavage medium (Cook Medical Inc., USA) in an atmosphere containing 6% CO 2 , 5% O 2 and 89% N 2 . Fertilization was assessed 17-19 h after insemination by examining the presence and number of pronuclei. Spare oocytes and embryos or those that were not of good quality were donated for research on Days 1-3 from consenting patients. A total of 164 oocytes and embryos were used in this study and the detailed description of their stages is listed in Supplementary data, Table SI.
Disaggregation of cleavage-stage embryos
In some experiments, cleavage-stage embryos were disaggregated before immunofluorescence. In these experiments, the embryos were incubated for 20-30 s in Acidic Tyrode's Solution (T1788) (Sigma-Aldrich Inc., Saint Louis, MO, USA) in order to remove the zona pellucidae. Zona-free embryos were then incubated for 2 h in Sydney IVF Cleavage Medium (G20720) (Cook Medical In some experiments a microtubule-stabilizing buffer was used to preserve microtubule structures. In these experiments, after collection the oocytes were fixed for 1 h at room temperature in the following microtubulestabilizing buffer (0.1 M Pipes, pH 6.9, 5 mM MgCl 2 , 2.5 mM EGTA) containing 2.0% (v/v) paraformaldehyde, 0.5% (v/v) Triton X-100, 1 mM taxol, 10 units/ml aprotinin and 50% (v/v) deuterium oxide (Messinger and Albertini, 1991) , washed three times in IF buffer and blocked in 5% (v/v) fetal bovine serum, 0.1% (v/v) Triton X-100 in PBS1× for 1 h. The samples that were either fixed with 4% (v/v) paraformaldehyde (PFA) or with the microtubule-stabilizing buffer were incubated for an overnight at 48C with one or two of the following primary antibodies, Goat anti-NLRP7 (sc-50642, 1:100) (Santa Cruz Biotechnology, Inc., Dallas, TX, USA); Rabbit anti-NLRP7 (IMG-6357A, 1:100) (Novus Biologicals, Littleton, CO, USA); Rabbit anti-NLRP7 (GXT120931, 1:100) (Gene Tex Inc., Irvine, CA, USA); Rabbit anti-KHDC3L (AP11238a, 1:100) (Abgent Inc., San Diego, CA, USA); Rabbit anti-KHDC3L (HPA043699, 1:100) (Sigma); Mouse anti-a-tubulin that recognizes the protein coded by TUBA4A (T6074, 1:1000) (Sigma); Mouse anti-E-cadherin (CDH1) (13-1700, 1:100) (Invitrogen Inc., Carlsbad, CA, USA) to visualize the transmembrane adhesion proteins at the cell-to-cell contact region; Mouse anti-NANOG (4893, 1:100) (Cell signaling technology, Boston, MA, USA) to visualize inner cell mass cells. NLRP7 and/or KHDC3L antibodies used in most of the immunofluorescence experiments were sc-50642 and AP11238a, respectively, and in these cases, the catalog numbers and names of the suppliers are not indicated. Occasionally, when other antibodies to reveal NLRP7 and KHDC3L were used, the names of the suppliers or references are specified.
After an overnight incubation with the primary antibodies, the samples were washed with IF buffer and incubated with the following secondary antibodies, Alexa 488-or Alexa 568-conjugated secondary antibodies (1:500) (Invitrogen) for 1 h at room temperature and was followed by three washes in IF buffer. Finally, the oocytes or embryos were transferred onto slides, coverslipped and mounted using Vectashield hard-set mounting medium containing 4-6-diamidino-2-phenylindole-2-HCl (DAPI) (H-1200) (Vector Laboratories, Burlingame, CA, USA) to visualize the nuclei. The specificity and validation of the main antibodies used to reveal NLRP7 and KHDC3L were reported previously (Messaed et al., 2011; Reddy et al., 2013) . Fluorescence images were captured using a laser scanning confocal microscope either Olympus FluoViewTM FV1000 or Leica SP8 (for Fig. 3a ). Optical sections of 1 mm were obtained and the imaging parameters were set using the greyscale function in the Olympus FluoViewTM FV1000 software. Figure 3a was generated using Volocity software (http://www. perkinelmer.co.uk). In order to insure the highest possible quality images without saturation, confocal settings were adapted and the images were then exported as TIFF files and processed for final figure formatting.
Electron microscopy
Immunolabeling was performed before the embedding of the oocytes. After collection, oocytes were incubated with Goat anti-NLRP7 (1:100) (sc-50642) followed by incubation with rabbit anti-Goat IgG (1:20) conjugated to 10 nm gold particles (G5402) (Sigma) for 30 min at room temperature and then fixed with 2.5% (v/v) glutaraldehyde [Electron Microscopy Sciences (EMS), Hatfield, PA, USA], in 0.1 M sodium cacodylate buffer (pH 7.4) for an overnight at 48C. The oocytes were then post-fixed with 1% (v/v) osmium tetroxide (EMS), 1.5% (w/v) aqueous potassium ferrocyanide in 0.1 M sodium cacodylate buffer (EMS) for 2 h at 48C, dehydrated through a graded series of ethanol baths, and then embedded in Epon (EMS). Ultrathin sections (80-95 nm) were cut with a diamond knife (Diatome) (EMS) on a Leica Microsystems UCT ultramicrotome (Vienna, Austria) and transferred onto Cu 200_mesh TEM grids with Formvar support film (EMS). Sections on the grids were contrast stained with 2% (w/v) uranyl acetate and Reynold's lead (EMS). Samples were imaged with a FEI Tecnai 12 TEM (FEI, Hillsboro, OR, USA) at an accelerating voltage of 120 kV and images were collected with an AMT XR80C CCD camera (Advanced Microscopy Techniques Corp, Woburn, MA, USA).
Statistical analysis
For the statistical analysis of immunofluorescence images, three different sections (at z ¼ 50 mm, section thickness ¼ 1 mm) of either metaphase II oocytes or 2-cell embryos from three independent experiments were analyzed to measure NLRP7 signal intensities using AutoQuantX software (Media Cybernetics, Inc., USA; http://www.mediacy.com). Measurements were performed on three regions indicated in Fig. 1f as the cortical (I and III) or central (II) regions for the metaphase II oocyte and in Fig. 4b as the cortical (I and III) or the cell-to-cell contact region (II) for the 2-cell embryos. All the data points generated by the software in each region were averaged. Then, the averages of NLRP7 signal in each region between all three images were calculated. Standard deviations were calculated for the averages generated for the three images. Statistical significance was performed using two-tailed t-test by comparing the average values obtained in regions I, II and III in the oocytes and the 2-cell embryos. P-values ,0.05 were considered statistically significant.
For the TEM image analysis, four different sections of a metaphase II oocyte (section thickness ¼ 95 nm) were used to count the number of immunogold particles from the cortex toward the center of the oocyte using Image J software (National Institutes of Health, USA; http://imagej.nih.gov/ij). The three regions in which the counts were performed are shown in Fig. 2b where interval 1 represents the region between 1 and 1000 nm from the oocyte membrane, region 2 represents the interval between 1000 and 2000 nm and region 3 represents the interval that goes beyond 2000 nm from the oocyte membrane. The total number of immunogold particles in each region was calculated for each image. Then, the averages and standard errors of the means (SEM) in each region between all four images were calculated and represented in the histograms. Statistical significance testing was performed using two-tailed t-test by comparing the values obtained in each region for the four images. P-values ,0.05 were considered statistically significant.
Results
NLRP7 and KHDC3L localize to the oocyte cortical region
So far NLRP7 expression in oocytes has been documented only by immunohistochemistry, which does not provide information about its precise subcellular localization. To gain further information about NLRP7 localizes to the oocyte cytoskeleton NLRP7 protein localization in the cells where it plays its primary role, we performed an extensive analysis on spare oocytes from patients undergoing assisted reproductive technologies. Using immunofluorescence, NLRP7 was found to localize to the cortical region in the germinal vesicle stage oocytes (Fig. 1a) , metaphase II oocytes (Fig. 1b) and fertilized eggs (Fig. 1c) . In addition, NLRP7 was also detected in the polar bodies (Fig. 1c) . The specificity of NLRP7 signal was checked after neutralizing the primary antibody with the peptide used to raise it, according to the manufacturer's instructions, and subsequent revelation by immunofluorescence. We found that the peptide blocked completely NLRP7 signal (Supplementary data, Fig. S1a-c) , which demonstrates the specificity of the signal. In all oocyte stages, NLRP7's signal displayed a gradient of decreasing intensities from the cortical region toward the center of the oocytes. Measuring the intensity of the NLRP7 signal on three metaphase II oocytes from different experiments revealed that the intensity of the signal in the cortical region is 3-fold higher than that observed in the center (P , 0.03; Fig. 1e and f) .
We then checked whether the NLRP7 intense cortical signal was caused by a technical artifact due to the incubation time and temperature with the primary antibody; the composition of the fixation buffer as previously shown for some proteins by Morency et al. (2011) ; or the antibody itself by testing two additional ones. However, the NLRP7 cortical signal did not change significantly with all the tested conditions (Supplementary data, Figs S2 and S3). We note that NLRP7's signal in the zona pellucida was not seen with the two additional antibodies, which indicates that the zona pellucida staining obtained with the main antibody (sc-50642) is most likely an artifact. We then extracted the oocytes with 0.1% (v/v) Triton X-100 1% (v/v) dimethyl sulfoxide in PBS1× for 5 min before fixation with PFA 4% (v/v) in PBS 1× and performed double labeling experiments with NLRP7 and a-tubulin antibodies. We found that NLRP7 protein distribution was not affected by the treatment and remained mainly at the cortical region while a-tubulin antibody gave a clear filamentous network that was uniformly distributed throughout the cytoplasm (Fig. 2a-c) , which demonstrate appropriate protein extraction before fixation. Altogether, our data demonstrate that NLRP7 intense cortical signal is unlikely to be due to an experimental artifact, but reflects the higher concentration of the protein at the cortical region.
We next investigated the localization of KHDC3L in human oocytes at the metaphase II stage using two commercially available antibodies. KHDC3L was found expressed at this stage, mainly in the cortical region (Fig. 2d -f and Supplementary data, Fig. S4 ) similar to NLRP7 (Fig. 2b) . KHDC3L was also expressed in the polar bodies (Supplementary data, Fig. S5) , and was completely absent from the zona pellucida with the two analyzed antibodies (Fig. 2d -f and Supplementary data, Figs S4 and S5). The specificity of the KHDC3L primary antibody (AP11238a) was also tested after blocking with the KHDC3L peptide according to the manufacturer's instructions, which abolished completely its signal (Supplementary data, Fig. S1d-f ).
NLRP7 is part of the oocyte cytoskeleton structure
To gain further knowledge about NLRP7 localization in the oocytes, we fixed some oocytes with microtubule-stabilizing buffer, performed immunofluorescence and analyzed the oocytes with high magnification confocal microscopy. This treatment preserved the microtubules and revealed a very nice cytoskeleton staining with NLRP7 antibody that was again more intense at the cortical region and was localized between some round structures that were not stained with NLRP7 antibody (Fig. 3a) . To identify these round structures and further refine the localization of NLRP7 at the cortical region, we performed ultrastructure analysis of metaphase II oocytes by transmission electron microscopy ( Fig. 3b-d) and first looked at the morphology of the oocyte with a particular interest to identify the different components and structures that are present in the cortical region. As previously reported (Van Blerkom and Henry, 1988), we found that this region is highly rich in cortical granules, mitochondria, smooth endoplasmic reticulum and vacuoles (Fig. 3b) , which are embedded into some cytoskeletal structures. Immunostaining with NLRP7 antibody followed by electron microscopy revealed immunogold particles that were located between cortical granules, mitochondria and other organelles ( Fig. 3c and d) , on some structures that were not well preserved. These immunogold particles displayed a gradient of decreasing numbers from the membrane toward the center of the oocytes (P , 0.04; Fig. 3e ). To reveal the nature of the structures on which immunogold particles were bound, we fixed additional oocytes with the microtubule-stabilizing buffer, which allows simultaneous extraction and fixation and performed confocal microscopy using either NLRP7 or KHDC3L and a-tubulin antibodies (Fig. 3f -k) . This treatment preserved the structure of the oocyte microtubules and cytoskeleton and revealed with a-tubulin antibody a microtubule filamentous network that was evenly distributed in the cytoplasm ( Fig. 3g and h ; j and k) while NLRP7 and KHDC3L antibodies stained some cytoskeletal structures that were again more intense at the cortical region ( Fig. 3f -k ; l-n). In conclusion, these data suggest that NLRP7 and KHDC3L are part of the oocyte cytoskeleton and are more abundant at the cortical region.
NLRP7 is polar during early embryogenesis
Next, we investigated the distribution of NLRP7 in preimplantation embryos from 2-cell to blastocyst stages. In humans, the thickness of NLRP7 localizes to the oocyte cytoskeleton the 2-cell embryo is 100 mm. In the middle section of 2-cell stage embryos (at 50 mm), NLRP7 signal was found polar with a gradient of decreasing intensities from the outer cortical region to the cell-to-cell contact region, where NLRP7 was completely absent (P , 0.006; Fig. 4a and b) . To investigate NLRP7 polarity throughout the threedimensional structure of the 2-cell embryo, we measured the intensities of its signal from the slide level (0 mm) to the top level (100 mm) using the z stack confocal option. At 40 and 60 mm, NLRP7 signal was present in the inner part of the cells but was less intense than in the cortical region ( Fig. 4c and d) . At 30 and 70 mm, NLRP7 signal in the inner part was higher than at 40 and 60 mm, respectively (data not shown). This pattern was reproduced in three different experiments and on three different 2-cell embryos (Fig. 4b) , which demonstrates the threedimensional polarity of NLRP7 in 2-cell embryos with a predominant location to the outer cortical part of the cells.
We next performed double labeling experiments with NLRP7 and E-cadherin, a transmembrane adhesion protein that attach blastomeres one to another after the completion of the first cell division via calciumdependent homotypic interactions (De Vries et al., 2004;  Fig. 4e -g ). This analysis showed the presence of E-cadherin at the cell-to-cell contact region demonstrating therefore that the absence of NLRP7 at the cell-to-cell contact is not due to incomplete permeabilization of the . Each region is delimited by a double arrow curve. Interval 1 indicates the region from 1 to 1000 nm from the oocyte membrane, 2 indicates the region from 1000 to 2000 nm from the oocyte membrane and 3 the region of more than 2000 nm from the membrane and toward the center of the oocyte. (f -k) Expression of NLRP7 (green) and KHDC3L (Sigma) (magenta) at the cortical region with a-tubulin in the cytoplasm of two different denuded metaphase II oocytes treated with a microtubule-stabilizing buffer. Bars, 50 mm. (l -n) Co-localization of NLRP7 (green) and KHDC3L (Sigma) (magenta) at the cortical region in a different denuded metaphase II oocyte treated with a microtubule-stabilizing buffer. DAPI (blue) stains the nuclei of the oocytes. Bar, 50 mm. cells, inaccessibility of the antibody, or technical issues affecting the transmission and detection of fluorescence. Dissociation of blastomeres from 2-to 8-cell embryos using calcium-free culture media resulted in a quick re-distribution of NLRP7 to the same uniform, cortical, localization observed in oocytes (Fig. 4h-j) . The same uniform and cortical distribution of NLRP7 was also observed in decompacted blastomeres of two degenerated embryos that were processed for immunofluorescence ( Fig. 4k and l) . This indicates that NLRP7 protein is not soluble and free in the oocytes, but is part of some cytoskeletal structures that are maintained in good-quality embryos but lost upon embryo degeneration. We note that in several embryos, blastomeres undergoing apoptosis expressed higher amount of NLRP7. Three of these embryos are shown in Figs 4h, 5f and i. The polarity of NLRP7 was maintained until the morula stage (Fig. 5) , but disappeared at the blastocyst stage NLRP7 localizes to the oocyte cytoskeleton where NLRP7 was homogenously distributed in the cytoplasm of cells from both the trophectoderm and the inner cell mass (Fig. 6) . In this experiment, NANOG, was used to identify inner cell mass cells. KHDC3L polarity was maintained until the morula stage where it started to become nuclear in some blastomeres but excluded from the nucleoli (Fig. 5j -o) . At the blastocyst stage, KHDC3L remained nuclear and was expressed in both the inner cell mass and the trophoblast layer (Fig. 6f -m) . Our data on early embryos demonstrate that NLRP7 and KHDC3L are both polar localized to the outer part of the cortical region during early cleavage stages.
Discussion
To date, several maternal-effect genes have been identified in mice and the subcellular localization of some of their proteins, OOEP, NLRP5, TLE6, FILIA, PADI6, DNMT1O and cPLA2g, in the oocytes and early embryo cleavage stages has been described (Howell et al., 2001; Vitale et al., 2005; Li et al., 2008; Ohsugi et al., 2008; Yurttas et al., 2008; Kim et al., 2010; Yurttas et al., 2010; Morency et al., 2011 , Tashiro et al., 2011 . These studies have revealed that one of the main characteristics of these proteins is their cortical localization in the oocytes and their polar distribution toward the outer part of the cortical region from 2-cell to morula stages.
To gain insight about the subcellular localization of the proteins of the only two known maternal-effect genes in humans, NLRP7 and KHDC3L, we performed extensive analysis on a total of 164 human oocytes and preimplantation embryos using regular and confocal immunofluorescence and electron microscopies. We found that in oocytes, from the germinal vesicle until the formation of the zygote, NLRP7 localized mainly to the cortical region along with KHDC3L. Modifying a range of experimental parameters did not significantly alter NLRP7 signal and validated its higher concentration at the cortical region of the oocytes. Within the cortical region, electron and high-resolution confocal microscopies confirmed the localization of NLRP7 between cortical granules, mitochondria and other organelles on some cytoskeletal structures that did not overlap exactly with the a-tubulin microtubule network or display similar pattern by immunofluorescence. Similar cytoskeletal structures, called cytoplasmic lattices (CPLs), were identified in mouse oocytes and consist of bundled fibers (Capco et al., 1993) to which five maternal-effect proteins, OOEP, FILIA, NLRP5, PADI6, TLE6, have been shown to localize (Wright et al., 2003; Li et al., 2008; Tassi et al., 2010) . The exact roles of CPLs is not fully understood, but embryos from NLRP5, PADI6, OOEP (FLOPPED), TLE6 or FILIA null females arrest during preimplantation development due to various defects that include impaired embryonic transcription (Tong et al., 2000) , dysregulation of de novo protein synthesis (Yurttas et al., 2008) , mitotic spindle abnormalities (Zheng and Dean, 2009 ), asymmetric first cell division (Zheng and Dean, 2009 ), delayed 1-to 2-cell division (Zheng and Dean, 2009 ). In addition, these CPLs were demonstrated to remain insoluble following treatment of oocytes with Triton X-100 (McGaughey and Capco, 1989; Capco et al., 1993) , which is in agreement with our data on NLRP7 signal that persisted to be predominant at the cortical region even after extraction of the oocytes with Triton X-100. These data suggest that NLRP7 is indeed part of these detergentresistant cytoskeletal structures that are abundant at the oocyte cortical region.
As the embryo completed its first division, NLRP7 and KHDC3L became excluded from the cell-to-cell contact region, were asymmetrically restricted, to the outer cortical regions and were part of some structural complexes that are not E-cadherin dependent. During early cleavage stages, NLRP7 was polar until the blastocyst stage where it lost its polarity and became homogeneously distributed in the cytoplasm of the inner cell mass and the trophectoderm. KHDC3L was polar until the morula stage where it entered and remained in the nuclei of both the inner cell mass and the trophectoderm layer. The fact that both NLRP7 and KHDC3L are maternal-effect genes that cause the same disease suggests that stages displaying their identical subcellular localization, oocytes to morula, are the most critical ones for the development of RHMs. This suggestion is corroborated by the preimplantation abnormalities observed in patients with mutations in KHDC3L (Reddy et al., 2013) and rare variants in NLRP7 (Deveault et al., 2009; Qian et al., 2011) , and is further supported by data on other maternal-effect genes such as (i) Nlrp2, the closest gene to NLRP7, whose knock-down in mice leads to embryonic arrest between 2-and 8-cell stages (Peng et al., 2012) ; (ii) Nlrp5, whose knockout in mice leads to embryonic arrest at the 2-cell stage (Tong et al., 2000) ; and (iii) Filia, whose knockout leads to arrest of 50% of the embryos by the morula stage (Ohsugi et al., 2008) . Because molar tissues from patients with NLRP7 and KHDC3L mutations lack DNA methylation at several imprinted, maternally expressed genes ( NLRP7 localizes to the oocyte cytoskeleton 2008; Hayward et al., 2009) , it was suggested that both NLRP7 and KHDC3L play a role in establishing or maintaining maternal methylation during oogenesis and/or early embryogenesis. The fact that KHDC3L translocates to the nuclei at the 8-cell stage similar to another maternal-effect protein in mice, DNMT1O (Howell et al., 2001) , suggest some shared roles between the two proteins, perhaps in maintaining DNA methylation patterns at the 8-cell embryo stage and before lineage differentiation.
In conclusion, our study provides the first detailed and high-resolution localization of the only two known maternal-effect proteins, NLRP7 and KHDC3L, in human oocytes and preimplantation embryos. We demonstrate their cytoskeletal localization in the oocytes and polarity throughout post-zygotic division. Our data suggest that NLRP7 and KHDC3L could be involved in the integrity and organization of the oocyte cortical region. In addition, their ability to redistribute during early cleavage stages indicate their possible involvement in sequestering macromolecules that may trigger, either directly or indirectly, the commitment of outer and inner cells to become, respectively, trophoblast and embryos, a process that was also suggested for FILIA and NLRP5 complex (Ohsugi et al., 2008) .
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